Empagliflozin

본문 바로가기


Home > Product > Empagliflozin
Selling leads
Empagliflozin
Posting date : Jun 30, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Net (Empagliflozin), according to Mr Column by boehringer ingelheim and eli lilly company joint development of a type 2 sodium synergy of glucose transporters (SGLT - 2, sodium - dependentglucosecotransporterChemicalbook2) inhibitors. SGLT-2 inhibitors are a new type of hypoglycemic drugs. They mainly reduce the reabsorption of glucose by the kidneys and increase the excretion of glucose in urine by inhibiting the expression of SGLT-2, thereby reducing the plasma glucose level. Their hypoglycemic effect does not depend on β -cell function and insulin resistance.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top